Literature DB >> 12069989

Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus.

Laura J V Piddock1, Yu Fang Jin, Mark A Webber, Martin J Everett.   

Abstract

A ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus (F145) contained no mutations within gyrA, gyrB, grlA, and grlB or within norA or its promoter region. MICs and accumulation studies suggest the role of a novel multidrug efflux pump.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12069989      PMCID： PMC127307          DOI： 10.1128/AAC.46.7.2276-2278.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.

Authors:  N Moniot-Ville; J Guibert; N Moreau; J F Acar; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  S Sreedharan; L R Peterson; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

3.  A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  P G Mortimer; L J Piddock
Journal:  J Antimicrob Chemother       Date:  1991-11       Impact factor: 5.790

4.  Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus.

Authors:  G W Kaatz; S M Seo; L O'Brien; M Wahiduzzaman; T J Foster
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

5.  Whole genome sequencing of meticillin-resistant Staphylococcus aureus.

Authors:  M Kuroda; T Ohta; I Uchiyama; T Baba; H Yuzawa; I Kobayashi; L Cui; A Oguchi; K Aoki; Y Nagai; J Lian; T Ito; M Kanamori; H Matsumaru; A Maruyama; H Murakami; A Hosoyama; Y Mizutani-Ui; N K Takahashi; T Sawano; R Inoue; C Kaito; K Sekimizu; H Hirakawa; S Kuhara; S Goto; J Yabuzaki; M Kanehisa; A Yamashita; K Oshima; K Furuya; C Yoshino; T Shiba; M Hattori; N Ogasawara; H Hayashi; K Hiramatsu
Journal:  Lancet       Date:  2001-04-21       Impact factor: 79.321

6.  Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae.

Authors:  Laura J V Piddock; M M Johnson
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

7.  Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.

Authors:  E Y Ng; M Trucksis; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

8.  Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.

Authors:  L Ferrero; B Cameron; B Manse; D Lagneaux; J Crouzet; A Famechon; F Blanche
Journal:  Mol Microbiol       Date:  1994-08       Impact factor: 3.501

9.  Inducible NorA-mediated multidrug resistance in Staphylococcus aureus.

Authors:  G W Kaatz; S M Seo
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

10.  Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA.

Authors:  J L Muñoz-Bellido; M Alonzo Manzanares; J A Martínez Andrés; M N Guttiérrez Zufiaurre; G Ortiz; M Segovia Hernández; J A García-Rodríguez
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191
View more
  7 in total

1.  New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.

Authors:  Antti J Hakanen; Marianne Lindgren; Pentti Huovinen; Jari Jalava; Anja Siitonen; Pirkko Kotilainen
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Accuracy of Different Bioinformatics Methods in Detecting Antibiotic Resistance and Virulence Factors from Staphylococcus aureus Whole-Genome Sequences.

Authors:  Amy Mason; Dona Foster; Phelim Bradley; Tanya Golubchik; Michel Doumith; A Sarah Walker; Angela Kearns; Tim Peto; N Claire Gordon; Bruno Pichon; Zamin Iqbal; Peter Staves; Derrick Crook
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

3.  Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments.

Authors:  Jeffrey J Campion; Patrick J McNamara; Martin E Evans
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.

Authors:  María Pérez-Vázquez; Federico Román; Belén Aracil; Rafael Cantón; José Campos
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 5.  Efflux-mediated drug resistance in bacteria.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.

Authors:  Phelim Bradley; N Claire Gordon; Timothy M Walker; Laura Dunn; Simon Heys; Bill Huang; Sarah Earle; Louise J Pankhurst; Luke Anson; Mariateresa de Cesare; Paolo Piazza; Antonina A Votintseva; Tanya Golubchik; Daniel J Wilson; David H Wyllie; Roland Diel; Stefan Niemann; Silke Feuerriegel; Thomas A Kohl; Nazir Ismail; Shaheed V Omar; E Grace Smith; David Buck; Gil McVean; A Sarah Walker; Tim E A Peto; Derrick W Crook; Zamin Iqbal
Journal:  Nat Commun       Date:  2015-12-21       Impact factor: 14.919

7.  Epidemiology and antimicrobial resistance of staphylococci isolated from different infectious diseases.

Authors:  Gamal Fadl M Gad; Abd El-Ghafar; Ramadan A A El-Domany; Zeinab Shawky Hashem
Journal:  Braz J Microbiol       Date:  2010-06-01       Impact factor: 2.476
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.